Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

OPK

OPKO Health, Inc. · Healthcare · Medical - Diagnostics & Research

1.50 +0.3% mkt cap $1.12B quote delayed (FMP) · as of Aug 26 18:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
11Tracked holders
+1Δ holders
16.46MShares held
$24.53MReported value
+1New positions
−0Exits
Strongly Rising Conviction score 57/100 How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +10.0% · share flow +22.9% · net new positions +9.1%formula
Broad accumulation — rising shares across more holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 83 -5 114.41M $171.44M +3 −8
Q1 2026 91 +2 116.06M $132.34M +8 −6
Q4 2025 88 0 132.71M $167.24M +1 −1
Q3 2025 15 -2 100.01M $155.02M −3
Q2 2025 15 0 96.47M $127.34M +2 −2
Q1 2025 12 +1 38.88M $64.54M +2 −1
Q4 2024 11 -1 30.02M $44.13M −1
Q3 2024 11 +1 16.46M $24.53M +1
Q2 2024 10 13.40M $16.75M
Holder count
Who holds it · Q3 2024
#ManagerSharesΔ sharesValueTheir weightHeld
1 Geode Capital Management (passive) 8.37M -5.1% $12.48M 0.0% ▼ Trim 2 SEC ↗
2 Geode Capital Management (passive) 8.37M -5.1% $12.48M 0.0% ▼ Trim 2 SEC ↗
3 Citadel Advisors 2.50M +626.5% $3.73M 0.0% ▲ Add 2 SEC ↗
4 Citadel Advisors 2.50M +626.5% $3.73M 0.0% ▲ Add 2 SEC ↗
5 Millennium Management 2.48M +96.3% $3.69M 0.0% ▲ Add 2 SEC ↗
6 Norges Bank (passive) 1.13M -15.3% $1.68M 0.0% ▼ Trim 2 SEC ↗
7 Two Sigma Investments 697.90K +15.1% $1.04M 0.0% ▲ Add 2 SEC ↗
8 Renaissance Technologies 458.93K +61.2% $683,801 0.0% ▲ Add 2 SEC ↗
9 T. Rowe Price 436.95K +0.9% $652,000 0.0% ▲ Add 2 SEC ↗
10 GAMCO Investors 175.00K 0.0% $260,750 0.0% Held 2 SEC ↗
11 Marshall Wace 96.34K New $143,553 0.0% New 1 SEC ↗
12 AQR Capital Management 77.15K -3.4% $114,953 0.0% ▼ Trim 2 SEC ↗
13 AQR Capital Management 77.15K -3.4% $114,953 0.0% ▼ Trim 2 SEC ↗
14 Gotham Asset Management 39.51K -33.1% $58,862 0.0% ▼ Trim 2 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Marshall Wace $143,553 0.0%

Exited

No tracked exits this quarter.

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 231 holders, 200.30M shares, $226.79M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q3 2024 · Methodology · Get this via the API